Osteopontin is an inflammatory protein that has recently been described as a biomarker of Alzheimer’s disease (Chai et al., 2021) and multiple sclerosis (Agah et al., 2018). This evidence concerns the gene SPP1 and early-onset autosomal dominant Alzheimer disease.